Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Dynavax Technologies Corporation - Common Stock
(NQ:
DVAX
)
11.14
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dynavax Technologies Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
21 Stocks Moving in Wednesday's Pre-Market Session
↗
September 01, 2021
Gainers GBS Inc. (NASDAQ: GBS) rose 72.3% to $5.58 in pre-market trading. The company markets saliva test for diabetes management and previously announced collaboration on covid-...
Via
Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
↗
August 31, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
↗
August 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Topics
Intellectual Property
Why Dynavax Stock Is Skyrocketing 45.8% This Week
↗
August 27, 2021
One of the company's partners launched its COVID-19 vaccine in Taiwan.
Via
The Motley Fool
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
↗
August 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...
Via
Benzinga
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
↗
August 25, 2021
ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Why Coronavirus Stock Dynavax Crushed It Today
↗
August 23, 2021
There was some very good news on the authorization front for the company.
Via
The Motley Fool
Powered By Dynavax Adjuvant, Medigen COVID-19 Vaccine Launched In Taiwan
↗
August 23, 2021
Medigen Vaccine Biologics Corporation and Dynavax Technologies Corporation (NASDAQ: DVAX) announced the rollout of their COVID-19 vaccine, MVC-COV1901, in...
Via
Benzinga
Valneva Initiates Rolling Submission For COVID19 Vaccine Candidate In UK
↗
August 23, 2021
Valneva SE (NASDAQ: VALN) has commenced rolling submission for its COVID-19 vaccine candidate with the Medicines and Healthcare products Regulatory Agency (MHRA)...
Via
Benzinga
60 Biggest Movers From Yesterday
↗
August 24, 2021
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,...
Via
Benzinga
Return on Capital Employed Overview: Dynavax Technologies
↗
August 20, 2021
Pulled from Benzinga Pro data Dynavax Technologies (NASDAQ:DVAX) posted Q2 earnings of $9.17 million, an increase from Q1 of 67.85%. Sales dropped to $52.77 million, a 36.68%...
Via
Benzinga
Why Dynavax, Novavax, and Inovio Stocks Sank This Week
↗
August 20, 2021
Investors appeared to be rattled by the U.S. government's decision to move forward with booster doses of mRNA vaccines.
Via
The Motley Fool
Surprise! Here's the Cheapest COVID Vaccine Stock on the Market Right Now
↗
August 19, 2021
The least expensive COVID-19 vaccine stock right now isn't one of the leaders in the market -- at least not yet.
Via
The Motley Fool
Why Dynavax, Novavax, and Sorrento Soared This Week
↗
August 13, 2021
There were different reasons behind each of these COVID-19 vaccine stocks' big gains.
Via
The Motley Fool
28 Stocks Moving in Friday's Pre-Market Session
↗
August 06, 2021
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares rose 35.4% to $4.66 in pre-market trading after the company reported an Agreement to acquire exclusive rights for assignment of...
Via
Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
↗
August 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...
Via
Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
↗
August 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (...
Via
Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
↗
August 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 6, 2021
↗
August 06, 2021
Upgrades According to Wolfe Research, the prior rating for The AES Corp (NYSE:
Via
Benzinga
Why COVID Vaccine Stocks Moderna, BioNTech, Novavax, and Dynavax Soared This Week
↗
August 06, 2021
Each vaccine stock had its own separate catalyst.
Via
The Motley Fool
10 Biggest Price Target Changes For Thursday
↗
August 05, 2021
Keybanc boosted the price target for HubSpot, Inc. (NYSE:
Via
Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
↗
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Why Dynavax Stock Has Jumped 11% So Far This Week
↗
July 02, 2021
The company inked a significant supply deal for its vaccine adjuvant.
Via
The Motley Fool
Clover, Dynavax Ink Commercial Supply Agreement For CpG 1018 Adjuvant
↗
June 30, 2021
Clover Biopharmaceuticals and Dynavax Technologies Corporation (NASDAQ: DVAX) have executed the commercial supply agreement of Dynavax's CpG 1018TM...
Via
Benzinga
The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs
↗
June 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
Why COVID Vaccine Stocks Dynavax, Novavax, and Vaxart Are Sinking Today
↗
June 15, 2021
The declines appear to be caused simply by volatility that's common with small biotech stocks.
Via
The Motley Fool
Valneva Concludes Recruitment for COVID-19 Vaccine Candidate Trial
↗
June 03, 2021
Privately-held Valneva SE has completed recruitment for the pivotal Phase 3 trial of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. VLA2001...
Via
Benzinga
Why Dynavax Stock Is Rising Today
↗
May 27, 2021
The company signed a key deal to market its hepatitis B vaccine in Germany.
Via
The Motley Fool
Dynavax, Bavarian Nordic Ink Distribution Pact For Hepatitis B Vaccine In Germany
↗
May 27, 2021
Dynavax Technologies Corporation (NASDAQ: DVAX) has entered into a commercialization agreement with Bavarian Nordic for the marketing and distribution of HEPLISAV...
Via
Benzinga
India's Biological E To Make Johnson & Johnson's COVID-19 Shots: Reuters
↗
May 19, 2021
Johnson and Johnson (NYSE: JNJ) has joined hands with India-based Biological E Limited to manufacture its COVID-19 vaccine, alongside Biological E's COVID-19...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.